IMM
Click for more information
6.45% 29.0¢ immutep limited

prima biomed to release interim cvac clinical

  1. Kenny Powers
    7,577 Posts.
    lightbulb Created with Sketch. 33
    clock Created with Sketch.
    30/07/12
    09:45
    Post #: 10497720
    The faithful are slow this morning...


    Prima BioMed Ltd (ASX: PRR, NASDAQ: PBMD) (Prima, the Company) announces that it will be releasing interim results from its CVac™ clinical trial CAN-003 in October 2012.
    PRR Price at posting: 10.2¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
-0.020(6.45%) 		Mkt cap ! $421.2M
Open High Low Value Volume
31.5¢ 31.5¢ 28.0¢ $2.100M 7.109M

Buyers (Bids)

No. Vol. Price($)
14 233293 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 36945 2
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.